Skip to main navigation Skip to search Skip to main content

No significant prognostic value of normal precursor B-cell regeneration in paediatric acute myeloid leukaemia after induction treatment

  • Anne E. Bras
  • , Marry M. Van den Heuvel-Eibrink
  • , Alita J. Van der Sluijs-Gelling
  • , Eva A. Coenen
  • , Henk Wind
  • , C. Michel Zwaan
  • , Jeroen G. Te Marvelde
  • , Mirjam Van der Burg
  • , Brenda Gibson
  • , Anita W. Rijneveld
  • , Valérie De Haas
  • , Jacques J.M. Van Dongen
  • , Vincent H.J. Van der Velden

Research output: Contribution to journalArticlepeer-review

6 Citations (Scopus)

Abstract

B-cell precursors (BCP) regeneration in bone marrow (BM) after induction chemotherapy is prognostic for good treatment response in adult acute myeloid leukaemia (AML). We detected BCP regeneration in 81% of 59 paediatric AML patients at first complete remission; this compared to 46% in an adult study. BCP regeneration did not correlate with outcome or minimal residual disease levels. In 36 healthy BM controls, BCP levels were significantly higher in children as compared to adults. Therefore, BCP regeneration does not reflect good response to treatment in paediatric AML, possibly due to the relatively high base-line levels of BCP in children.

Original languageEnglish
Pages (from-to)861-864
Number of pages4
JournalBritish journal of haematology
Volume161
Issue number6
DOIs
Publication statusPublished - Jun 2013
Externally publishedYes

Keywords

  • AML
  • B-cells
  • MRD
  • Paediatric
  • Relapse

Fingerprint

Dive into the research topics of 'No significant prognostic value of normal precursor B-cell regeneration in paediatric acute myeloid leukaemia after induction treatment'. Together they form a unique fingerprint.

Cite this